Join the Kidney Health Initiative (KHI) for an informal virtual discussion on opportunities to evaluate clinical trial endpoints for transplant immunosuppression drugs.
KHI is planning a pre-competitive and collaborative project to catalyze the development of novel immunosuppression drugs, given the limited choices available for transplant recipients. KHI seeks feedback to ensure that a collaborative solution addresses the stagnation in this space.
Don’t miss this opportunity to share your thoughts and perspectives on aligning the pathway for transplant immunosuppression endpoints.